1.
2.
Novocure data breach affects more than 1,400 cancer patients
(bleepingcomputer.com)
3.
Reply to: Pre-clinical data interpretation requires clinical context
(feeds.nature.com)
4.
AstraZeneca Sees 2030 Goal on Track as Cancer Drugs Drive Growth
(feeds.content.dowjones.io)
5.
6.
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
(feeds.content.dowjones.io)
7.
8.
Daily pill can double survival time for deadliest cancer, trial shows
(news.ycombinator.com)
9.
Triomics nabs $22M to bring oncology-specific AI to cancer centers
(techcrunch.com)
10.
Early-onset cancer fuels calls for wider screening — but at what cost?
(feeds.nature.com)
11.
Gilead Sciences to Buy Clinical-Stage Biotech Tubulis for Up to $5 Billion
(feeds.content.dowjones.io)
12.
Engaging the head and the heart: why scientists turn to poetry
(feeds.nature.com)
13.
AstraZeneca’s Imfinzi Gets Expanded EU Label With Approval for Gastric Cancer
(feeds.content.dowjones.io)